recall
saveMylan Institutional, Inc. recall (Cls II)
December 18, 2024updated 5mo ago
community read0 votes
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-040-20 — Reason: Subpotent and Superpotent Drug — Status: Ongoing
view source ↗Data sources
last refreshed 22m ago
Found something off?
same company · ±60 days · 5
🐶 often sniffed alongside
top 8- tagApproval56 co-mentions · 28 sources
- drugremifentanil hydrochloride35 co-mentions · 18 sources
- drugULTIVA35 co-mentions · 18 sources
- drugmethadone hydrochloride ODT9 co-mentions · 9 sources
- drugMETHADONE HYDROCHLORIDE9 co-mentions · 9 sources
- drugMETHADOSE9 co-mentions · 9 sources
- tagRecall9 co-mentions · 9 sources
- druglevothyroxine sodium8 co-mentions · 8 sources
comments(0)
5-min edit window · permanent after that